2009 Mid-Atlantic Bio

The 2009 Mid-Atlantic Bio conference will bring together more than 850 national and international industry leaders, government representatives, executives, researchers, investors, entrepreneurs, and professional services firms—representing 30 states and 10 countries—in a unique forum to promote networking, business expansion, and technical-knowledge sharing.

This year, the conference will feature a Healthcare Policy Panel. Experts will arm conference attendees with insider information that will refine their organization’s strategic planning based on recent federal health reform legislation, continuing impacts from the current economic environment, and the opportunity to benefit from federal stimulus funds.

Healthcare Policy Panel speakers include Senator Ben Cardin (D-Md.), Representatives Charles Boustany (R-La.) and Anna Eshoo, (D-Calif.), and Tony Zook, CEO of AstraZeneca North America. Steve Usdin, Senior Editor, BioCentury Publications, Inc., will moderate the panel.

Representative Bob Goodlatte (R-Va.) will make remarks at the CEO & Investor Reception.
Testimonials

Washington Business Journal Vandana Sinha, names Mid-Atlantic Bio: “the region’s most well-known gathering for biotech professionals.”

Charlottesville Daily Progress writes, “Charlottesville’s local biotechnology sector will make a big showing at a regional conference in the nation’s capital. Biotechnology firms from the Charlottesville area will make up six of the 24 presenters at the 2009 Mid-Atlantic Bio Conference from Nov. 4-6 at Washington’s Convention Center.”

Frederick News-Post writes, “Mid-Atlantic Bio has quickly gained recognition as a substantive, regionally hosted forum and a popular place for members of the local bioscience industry to gather…[a]long with numerous marketing and networking opportunities.”

Frederick News-Post also writes, “The Mid-Atlantic region is lucky to have what has quickly become recognized as one of the best local conferences…Mid-Atlantic Bio.”
Plenary Speakers

For the 2009 Mid-Atlantic Bio Conference, plenary speakers include Randal Kirk, CEO of Third Security and Intrexon; Tony Zook, CEO of AstraZeneca North America and President of MedImmune; and, Tom Watkins, CEO of Human Genome Sciences. More information on the plenary speakers may be found here.

What is new this year! Bioscience and Biofuels. The worldwide demand for biotechnology to serve the need for energy and environmental solutions has created a wave of new opportunities for biotech companies. This year we will feature a panel: “Biofuels: How Bioscience Companies Can Provide Solutions” where industry experts will discuss the latest developments, federal grants, joint ventures and share how Mid-Atlantic bioscience firms can play a role in this high-profile new industry.
Latest News

* Washington Business Journal Article: Howard Dean to speak at Mid-Atlantic Bio — Oct 30, 2009
* Howard Dean and Rep. Boustany to Speak at the 2009 Mid-Atlantic Bio Conference — Oct 29, 2009
* Business Gazette Article: Industry gears up for mid-Atlantic conference — Oct 29, 2009
* Mid-Atlantic Bio in WBJ: D.C.-area biotechs set to pitch investors at Mid-Atlantic Bio — Oct 26, 2009
* Mid-Atlantic Bio in Charlottesville Daily Progress — Oct 25, 2009
* Presenting Companies Announced for 2009 Mid-Atlantic Bio Conference — Oct 21, 2009
* Poll Finds Support for Corn Ethanol — Oct 20, 2009
* Vilsack: For Locally Grown Food, Not Against GMOs — Oct 13, 2009
* A Clear Line on Stem Cells: Congress Can Codify Sensible NIH Research Rules — Oct 10, 2009
* Berkshire Partners Invests in United BioSource — Oct 09, 2009